Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical Nephrology

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 11334311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-18 and Interleukin-12 Synergize to Stimulate the Production of Vascular Permeability Factor by T Lymphocytes in Normal Subjects and in Patients with Minimal-Change Nephrotic Syndrome

  2000cited by this paper
• Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome.

  1999cited by this paper
• Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.

  1999cited by this paper
• VEGF(165) mediates glomerular endothelial repair.

  1999cited by this paper
• Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: localization and [125I]VEGF binding sites.

  1998cited by this paper
• Interleukin 12 Upregulates the Release of Vascular Permeability Factor by Peripheral Blood Mononuclear Cells from Patients with Lipoid Nephrosis

  1998cited by this paper
• Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.

  1996cited by this paper
• Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases.

  1996cited by this paper
• Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.

  1995cited by this paper
• Decreased release of IL‐10 by monocytes from patients with lipoid nephrosis

  1995cited by this paper
• Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor.

  1993cited by this paper
• Anti-inflammatory actions of steroids: molecular mechanisms.

  1993cited by this paper
• Vascular permeability factor mRNA and protein expression in human kidney.

  1992cited by this paper
• IL-10 inhibits cytokine production by activated macrophages.

  1991cited by this paper
• A retrospective analysis of the natural history of primary IgA nephropathy worldwide.

  1990cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper
• Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

  1989cited by this paper

• Urinary Markers of Podocyte Dysfunction in Chronic Glomerulonephritis.

  2021cites this paper
• Physiopathologie des syndromes néphrotiques idiopathiques

  2019cites this paper
• Pathogenesis of Minimal Change Nephrotic Syndrome: A Review of the Underlying Molecular Mechanisms

  2019cites this paper
• Correlation Between Idiopathic Nephrotic Syndrome and Atopy in Children - Short Review.

  2017cites this paper
• History of Research on Pathogenesis of Idiopathic Nephrotic Syndrome

  2016cites this paper
• Steroid Sensitive Nephrotic Syndrome

  2016cites this paper
• Preoperative assessment and diagnosis of endometriosis: are we any closer?

  2015cites this paper
• The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial

  2015cites this paper
• Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes

  2015cites this paper
• The association between therapeutic outcomes and VEGF G-1154A and C-936T gene polymorphisms in patients with glomerulonephritis

  2014cites this paper
• Urinary vitamin D-binding protein is elevated in patients with endometriosis.

  2012cites this paper
• [Pathogenesis and treatment of idiopathic nephrotic syndrome in adults].

  2012cites this paper
• Understanding the Mechanisms of Proteinuria: Therapeutic Implications

  2012cites this paper
• The beneficial effects of plasma exchange for treatment of acute kidney injury in minimal change nephrotic syndrome

  2011cites this paper
• Relevance of VEGF and Nephrin Expression in Glomerular Diseases

  2011cites this paper
• Pathogenesis in Childhood Idiopathic Nephrotic Syndrome: An Update of Patchwork

  2009cites this paper
• Urinary Biomarkers in Diabetic Nephropathy and Other Glomerular Diseases

  2008cites this paper
• Evaluation of Serum and Urinary Angiogenic Factors in Patients with Endometriosis

  2007cites this paper
• Urine biomarkers predict the cause of glomerular disease.

  2007cites this paper
• The Relationship between the VEGF Levels and VEGF mRNA Expression and Clinical Course in Different Glomerulonephritis

  2007cites this paper
• Urinary excretion of endothelin-1 (ET-1), transforming growth factor- beta1 (TGF- beta1) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial.

  2007cites this paper
• Effect of tumor necrosis factor alpha and vascular permeability growth factor on albuminuria in rats.

  2006cites this paper
• Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy.

  2006cites this paper
• Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A

  2006cites this paper
• Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome

  2006cites this paper
• Genetic Polymorphism of Vascular Endothelial Growth Factor: Impact on Progression of IgA Nephropathy

  2006cites this paper
• Effect of tumor necrosis factor α and vascular permeability growth factor on albuminuria in rats

  2006cites this paper
• The Role of Vascular Endothelial Growth Factor in Pathogenesis of Glomerulonephritis

  2006influential citation
• Untersuchungen zur Serumkonzentration des Vascular Endothelial Growth Factor ( VEGF ) bei Patienten im Rahmen einer

  2005cites this paper
• Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus

  2004cites this paper
• Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.

  2004cites this paper
• The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.

  2004influential citation
• The pediatric nephrotic syndrome spectrum: Clinical homogeneity and molecular heterogeneity

  2004cites this paper
• Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome.

  2004cites this paper
• Urine vascular endothelial growth factor-A is not a useful marker for endometriosis.

  2004cites this paper
• Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.

  2004cites this paper
• Hemoperfusion with Polymyxin B-Immobilized Fiber in Septic Patients with Methicillin-Resistant Staphylococcus aureus-Associated Glomerulonephritis

  2003cites this paper
• Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease?

  2003cites this paper
• Anaemia and risk of chronic vascular disease in chronic renal infection Related review: Anaemia, cardiovascular disease

  2003cites this paper